Dopaminergic regeneration by neurturin-overexpressing c 17.2 neural stem cells in a rat model of Parkinson's disease

Molecular Neurodegeneration

Volumn 2, Issue 1, 2007, Pages

  Liu, Wei Guo ^a   Wang, Xi Jing ^a   Lu, Guo Qiang ^a   Li, Biao ^a   Wang, Gang ^a   Chen, Sheng Di ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

EID: 36249009002     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-2-19     Document Type: Article

References (23)

1. McGeer PL, Itagaki S, Akiyama H, McGeer EG: Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 1988, 24:574-576.
2. Olanow CW, Tatton WG: Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999, 22:123-144.
3. Betchen SA, Kaplitt M: Future and current surgical therapies in Parkinson's disease. Curr Opin Neurol 2003, 16:487-493.
4. Burton EA, Glorioso JC, Fink DJ: Gene therapy progress and prospects: Parkinson's disease. Gene Ther 2003, 10:1721-1727.
5. Dunnett SB, Bjorklund A: Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 1999, 399:A32-A39.
6. Vajda FJ: Neuroprotection and neurodegenerative disease. J Clin Neurosci 2002, 9:4-8.
7. Akerud P, Holm PC, Castelo-Branco G, Sousa K, Rodriguez FJ, Arenas E: Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease. Mol Cell Neurosci 2002, 21:205-222.
8. Leitner ML, Molliver DC, Osborne PA, Vejsada R, Golden JP, Lampe PA, Kato AC, Milbrandt J, Johnson EM Jr.: Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific. J Neurosci 1999, 19:9322-9331.
9. Golden JP, DeMaro JA, Osborne PA, Milbrandt J, Johnson EM Jr.: Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Exp Neurol 1999, 158:504-528.
10. Cacalano G, Farinas I, Wang LC, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A: GFRalphal is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 1998, 21:53-62.
11. Horger BA, Nishimura MC, Armanini MP, Wang LC, Poulsen KT, Rosenblad C, Kirik D, Moffat B, Simmons L, Jr JE, Milbrandt J, Rosenthal A, Bjorklund A, Vandlen RA, Hynes MA, Phillips HS: Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci 1998, 18:4929-4937.
12. Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA, Cepko CL: Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992, 68:33-51.
13. Liu WG, Lu GQ, Li B, Chen SD: Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease. Parkinsonism Relat Disord 2007, 13:77-88.
14. Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
15. Foley P, Riederer P: Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. J Neurol 2000, 247 Suppl 2:1182-1194.
16. Jenner P, Olanow CW: Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996, 47:S161-S170.
17. Jenner P: Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol Scand Suppl 1993, 146:6-13.
18. Rosenblad C, Kirik D, Devaux B, Moffat B, Phillips HS, Bjorklund A: Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur J Neurosci 1999, 11:1554-1566.
19. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY: Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 2002, 20:1103-1110.
20. Yang M, Stull ND, Berk MA, Snyder EY, Iacovitti L: Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. Exp Neurol 2002, 177:50-60.
21. Yang M, Donaldson AE, Jiang Y, Iacovitti L: Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells. Cell Mol Neurobiol 2003, 23:851-864.
22. Lu P, Jones LL, Snyder EY, Tuszynski MH: Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003, 181:115-129.
23. Harding AJ, Halliday GM, Cullen K: Practical considerations for the use of the optical disector in estimating neuronal number. J Neurosci Methods 1994, 51:83-89.